To include your compound in the COVID-19 Resource Center, submit it here.

Extended-release Janumet sitagliptin/metformin regulatory update

Merck received a complete response letter from FDA

Read the full 84 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE